In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


SurModics expands with Brookwood buy:

This article was originally published in Clinica

Executive Summary

Drug delivery technology provider SurModics has acquired Brookwood Pharmaceuticals, a subsidiary of the Southern Research Institute, for $40m in cash. The deal, which could rise by a further $22m pending the achievement of specific milestones, sees SurModics (Eden Prairie, Minnesota) gain proprietary polymer-based technologies and broaden its range of markets to include oncology, ophthalmology and orthopaedics. Brookwood, which will retain its operating facilities in Birmingham, Alabama, recorded $12.7m in revenues in 2006, and is profitable and cash flow positive, so is expected to be accretive to SurModics' fiscal 2008 earnings.






Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts